Objectively assessed secondhand smoke exposure and mental health in adults: Cross-sectional and prospective evidence from the Scottish health survey

Archives of General Psychiatry

Volumn 67, Issue 8, 2010, Pages 850-855

  Hamer, Mark ^a   Stamatakis, Emmanuel ^a   Batty, G David ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DISTRESS SYNDROME; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; GENERAL HEALTH QUESTIONNAIRE; HAZARD RATIO; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PASSIVE SMOKING; PROSPECTIVE STUDY; RISK ASSESSMENT; UNITED KINGDOM; ADOLESCENT; CHEMISTRY; COMPARATIVE STUDY; MENTAL DISEASE; MIDDLE AGED; RISK FACTOR; SALIVA; SMOKING;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; COTININE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SALIVA; SCOTLAND; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 77955875000     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.76     Document Type: Article

References (29)

1. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997;315(7114):973-980. (Pubitemid 27443124)
2. US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the US Surgeon General. Atlanta, GA: US Dept of Health & Human Services, Centers for Diseases Control and Prevention, Coordinating Center for Health Promotion, Office on Smoking and Health; 2006.
3. Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 2009;120(14):1373-1379.
4. Lodovici M, Bigagli E. Biomarkers of induced active and passive smoking damage. Int J Environ Res Public Health. 2009;6(3):874-888.
5. Tager IB. The effects of second-hand and direct exposure to tobacco smoke on asthma and lung function in adolescence. Paediatr Respir Rev. 2008;9(1):29-38.
6. Mills AL, Messer K, Gilpin EA, Pierce JP. The effect of smoke-free homes on adult smoking behavior: a review. Nicotine Tob Res. 2009;11(10):1131-1141.
7. Jefferis BJ, Lowe GD, Welsh P, Rumley A, Lawlor DA, Ebrahim S, Carson C, Doig M, Feyerabend C, McMeekin L, Wannamethee SG, Cook DG, Whincup PH. Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women. Atherosclerosis. 2010;208(2):550-556.
8. Houston TK, Person SD, Pletcher MJ, Liu K, Iribarren C, Kiefe CI. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ. 2006;332(7549):1064-1069.
9. Tunstall-Pedoe H, Brown CA, Woodward M, Tavendale R. Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study. J Epidemiol Community Health. 1995;49(2):139-143.
10. Whincup PH, Gilg JA, Emberson JR, Jarvis MJ, Feyerabend C, Bryant A, Walker M, Cook DG. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ. 2004;329(7459):200- 205.
11. Venn A, Britton J. Exposure to secondhand smoke and biomarkers of cardiovascular disease risk in never-smoking adults. Circulation. 2007;115(8):990-995. (Pubitemid 46328292)
12. Kassel JD, Stroud LR, Paronis CA. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull. 2003;129(2):270-304.
13. Iñiguez SD, Warren BL, Parise EM, Alcantara LF, Schuh B, Maffeo ML, Manojlovic Z, Bolaños-Guzmán CA. Nicotine exposure during adolescence induces a depression-like state in adulthood. Neuropsychopharmacology. 2009;34(6):1609-1624.
14. Bandiera FC, Arheart KL, Caban-Martinez AJ, Fleming LE, McCollister K, Dietz NA, LeBlanc WG, Davila EP, Lewis JE, Serdar B, Lee DJ. Secondhand smoke exposure and depressive symptoms. Psychosom Med. 2010;72(1):68-72.
15. Bridevaux PO, Cornuz J, Gaspoz JM, Burnand B, Ackermann-Liebrich U, Schindler C, Leuenberger P, Rochat T, Gerbase MW; SAPALDIA Team. Secondhand smoke and health-related quality of life in never smokers: results from the SAPALDIA cohort study 2. Arch Intern Med. 2007;167(22):2516-2523. (Pubitemid 350254913)
16. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry. 2006;63(7):808-816.
17. al'Absi M, Wittmers LE, Erickson J, Hatsukami D, Crouse B. Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers. Pharmacol Biochem Behav. 2003;74(2):401-410.
18. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171-186.
19. Scottish Government. Scottish health survey publications. http://www.scotland.gov.uk/Topics/Statistics/Browse/Health/scottish-health- survey/Publications. Accessed November 1, 2007.
20. Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997;27(1):191-197. (Pubitemid 27042731)
21. Hamer M, Stamatakis E, Steptoe A. Psychiatric hospital admissions, behavioural risk factors, and all cause mortality: the Scottish Health Survey. Arch Intern Med. 2008;168(22):2474-2479.
22. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77(11):1435-1438. (Pubitemid 18011591)
23. Jarvis MJ, Feyerabend C, Bryant A, Hedges B, Primatesta P. Passive smoking in the home: plasma cotinine concentrations in non-smokers with smoking partners. Tob Control. 2001;10(4):368-374. (Pubitemid 33720610)
24. Macintyre S, McKay L, Der G, Hiscock R. Socio-economic position and health: what you observe depends on how you measure it. J Public Health Med. 2003;25(4):288-294. (Pubitemid 38173599)
25. Hemmingsson T, Kriebel D. Smoking at age 18-20 and suicide during 26 years of follow-up: how can the association be explained? Int J Epidemiol. 2003;32(6):1000-1004.
26. Rao U, Hammen CL, London ED, Poland RE. Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents. Neuropsychopharmacology. 2009;34(13):2721-2732.
27. Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA. Effect of a history of major depressive disorder on smoking-induced dopamine release. Biol Psychiatry. 2009;66(9):898-901.
28. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-328. (Pubitemid 47094993)
29. Pell JP, Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C, McConnachie A, Pringle S, Murdoch D, Dunn F, Oldroyd K, Macintyre P, O'Rourke B, Borland W. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008;359(5):482-491.